BathGenBio

South Korea
Seoul, Seoul, South Korea, 1901

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$7.7M
Last funding
Series B / $2.3M / 2023-06-08
Last equity funding
Series B / $2.3M
Investors
2
Lead investors
1

Founders and investors

Lead investors

DS Asset Management

Investors

CelltrionDS Asset Management